Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granisetron for prevention of shivering during spinal anesthesia in children
ACTRN12611001059954Phase 4Completed
- Sponsor
- Yasser M. Amr
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of granisetron in postanesthetic shivering (PAS) (2 arms), sponsored by Yasser M. Amr. Primary endpoint: Incidence of shivering. Started May 2011; status: completed.
02
Drugs
granisetron
03
Conditions
postanesthetic shivering (PAS)
Beyond the preview
Go deeper on ACTRN12611001059954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611001059954.